¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"acute normal tissue effect"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® adverse effect ÇÑ±Û ¿ªÈ¿°ú, À¯ÇØÈ¿°ú
¼³¸í   
  ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§ ³ªÅ¸³ª´Â Ä¡·á¸ñÀû¿¡ ºÎÇÕµÇÁö ¾Ê´Â ºÒÄèÇÑ ÀÛ¿ë, Áï ºÎÀÛ¿ëÀ» ¿ªÈ¿°ú·Î Ç¥ÇöÇϴ °æ¿ì°¡ ÀÖ´Ù. ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼­´Â ¿ªÈ¿°ú¶õ ¡°¿¹¹æ, Áø´Ü, Ä¡·áÀÇ ¸ñÀûÀ¸·Î »ç¶÷¿¡°Ô »ó¿ë·®ÀÇ ¾àÀ» »ç¿ëÇÏ¿´À» ¶§ ¹ßÇöÇϴ Àå¾Ö·Î, ÀǵµÇÏÁö ¾ÊÀº Àۿ롱À̶ó°í Á¤ÀÇÇϰí ÀÖ´Ù. ¾à¹°¿¡ ÀÇÇÑ Ä¡·á¸¦ ÇÒ ¶§, Æ¯È÷ ÁÖ¸ñÇÏ¿©¾ß ÇÒ ÀϹÝÀûÀΠ¿ªÈ¿°ú·Î¼­ ¾à¹°¾Ë·¹¸£±â, Á¶Ç÷Àå±â Àå¾Ö, °£-ÄáÆÏÀÇ Àå¾Ö, ¹°Áú ´ë»ç Àå¾Ö µîÀÌ ÀÖ´Ù. ÀÌ ¿Ü¿¡ ÀÓ»êºÎ¿¡°Ô Åõ¿©ÇÏ¿© ¹ß»ýÇÑ ±âÇü¹ß»ý, ¸¶¾à, °¢¼ºÁ¦, ±âŸ ÇâÁ¤½ÅÁ¦¿¡ ÀÇÇÑ ÀÇÁ¸¼º Çü¼ºµµ Áß¿äÇÏ´Ù.
  
  
¿µ¹® acute hepatitis ÇÑ±Û ±Þ¼º°£¿°
¼³¸í   
  ¹ÙÀÌ·¯½º¿¡ ÀÇÇØ °£¿¡ »ý±â´Â ±Þ¼º¿°Áõ. ±Þ¼º°£¿°À̶õ °£¿°¹ÙÀÌ·¯½º(AÇü-BÇü-ºñAºñBÇü)¿¡ ÀÇÇØ¼­ °£¿¡ »ý±â´Â ±Þ¼º¿°ÁõÀ» º´¸íÀ¸·Î À̸£´Â ¸»·Î, À̴ ±× °¨¿°¾ç½Ä¿¡ ¼öÇ÷ ÈÄ¿¡ ¹ß»ýÇϴ ¼öÇ÷ÈÄ °£¿°°ú, °¨¿°°æ·Î¸¦ ¾Ë ¼ö ¾ø´Â »ê¹ß¼º°£¿° ¹× Áý´ÜÀ¸·Î ¹ß»ýÇϴ À¯Ç༱°£¿°ÀÇ ¼¼°¡Áö À¯ÇüÀ¸·Î ³ª´­ ¼ö ÀÖ´Ù. ¼öÇ÷ÈÄ °£¿°Àº ±× 95%°¡ ºñAºñBÇü°£¿°À̸砳ª¸ÓÁö°¡ BÇü °£¿°ÀÌ´Ù. »ê¹ß¼º °£¿°Àº AÇü °£¿°°ú BÇü °£¿°ÀÌ °¢°¢ 30%¸¦ ÀÌ·ç°í ³ª¸ÓÁö 40%´Â ºñAºñB°£¿°ÀÌ´Ù. Áý´ÜÀ¸·Î ¹ß»ýÇϴ À¯Ç༺°£¿°Àº °ÅÀǰ¡ AÇü°£¿°ÀÌÁö¸¸ ¶§·Î´Â ¿©±â¿¡ Æ÷ÇÔµÇÁö ¾ÊÀº ÇüÀÇ °£¿°ÀÏ °æ¿ìµµ ÀÖ´Ù. ±Þ¼º°£¿°ÀÇ Áõ¼¼´Â ¸ÕÀú ¸öÀÌ ³ª¸¥ÇØÁö°í ¿Â¸ö¿¡ ±ÇۨÀ̠ã¾Æ¿À¸ç Á¶±×¸¶ÇÑ ÀÏ¿¡µµ °ð ÇǷθ¦ ´À³¢°Ô µÈ´Ù. ±×¸®°í ½Ä¿åºÎÁø-¹ß¿­-±¸ÅäÁõ-º¹Åë-¼³»ç µî, °¨±â³ª ±Þ¼ºÀ§Àå¿°¿¡ °É·ÈÀ» ¶§¿Í °°Àº Áõ¼¼ µîÀÌ ³ªÅ¸³­´Ù. µÚÀ̾î È²´ÞÁõ¼¼¸¦ º¸À̴µ¥, À̶§´Â ÃʱâÀÇ Áõ¼¼°¡ ¾à°£ °¡º­¿öÁø °Íó·³ ´À²¸Áö´Â °ÍÀÌ º¸ÅëÀÌ´Ù. ±×·¯³ª È²´ÞÁõ¼¼°¡ ½ÉÇØÁö°í ÃʱâÀÇ Áõ¼¼µéÀÌ ´Ù½Ã ÁøÇàµÇ¸é À̶§´Â Àü°Ý¼º°£¿°ÀÌ µÉ À§ÇèÀÌ ÀÖ´Ù. °£¿° Áõ¼¼°¡ ½ÉÇÏÁö ¾Ê¾ÒÀ» °æ¿ì´Â È²´ÞÀÌ ´«¿¡ ¶çÁö ¾ÊÀº °æ¿ìµµ Àִµ¥ À̶§´Â ÁøÂûÀ» Çصµ °¨±â³ª ±Þ¼ºÀ§Ã¢ÀÚ¿°À¸·Î ÀÚÄ© ¿ÀÁøµÇ±â ½±´Ù. ¶Ç AÇü°£¿°Àº ¿­ÀÌ 38~39¡É±îÁö ¿À¸£°í Áõ¼¼°¡ °©Àڱ⠳ªÅ¸³ª´Â °ÍÀ̠Ư¡À̸砱޼ººñAºñBÇü°£¿°Àº Áõ¼¼°¡ ºñ±³Àû °¡º­¿î °ÍÀ̠Ư¡ÀÌ´Ù. ±Þ¼ºBÇü°£¿°ÀÇ Áõ¼¼´Â AÇü°£¿°°ú ±Þ¼ººñAºñBÇü°£¿°ÀÇ Áß°£ Á¤µµÀΠ°ÍÀÌ º¸ÅëÀÌ´Ù.
¿µ¹® acute appendicitis ÇÑ±Û ±Þ¼º¸·Ã¢ÀÚ²¿¸®¿°
¼³¸í   
  ¿Ü°úÀû Ã³Ä¡¸¦ ¿äÇϴ ¸·Ã¢ÀÚ²¿¸®(Ãæ¼ö)ÀÇ ±Þ¼º¿°ÁõÀ¸·Î¼­, º¸Åë ÇϺ¹ºÎÀÇ ¿À¸¥ÂÊ 1/4 ºÎÀ§¿¡¼­ÀÇ ÅëÁõÀ̠Ư¡À̸ç, ±¹¼Ò¾ÐÅë, ±ÙÀ°±äÀå ÇǺΰ¨°¢ÀÇ °ú¹Î µîÀ» ¼ö¹ÝÇÑ´Ù. ÀϹݵòµéÀÌ ¡°¸ÍÀå¿°¡±À̶ó°í Çϴ °ÍÀ¸·Î ¸ÍÀå¿°Àº ¸·Ã¢ÀÚÀÇ ¿°ÁõÀ¸·Î ±¸º°µÇ¾î¾ß ÇÑ´Ù. ¹ß¿­°ú ´ÙÇü¹éÇ÷±¸Áõ´Ù´Â ±¹¼Ò°¨¿°ÀÇ °á°úÀÌ´Ù. ¸·Ã¢ÀÚ²¿¸®ÀÇ À§Ä¡-À¯Âø»óÅÂ-²¿ÀÓ µî¿¡ ÀÇÇØ Áõ»ó°ú Â¡ÈĴ º¯µ¿µÈ´Ù.
¿µ¹® acute cholecystitis ÇÑ±Û ±Þ¼º¾µ°³¿°
¼³¸í   
  º¸Åë ¾µ°³ ÃⱸÀÇ Æó»ö¿¡ ÀÇÇÑ °ÍÀ̸ç, ¿°ÁõÀÇ Á¤µµ´Â °æµµÀÇ ºÎÁ¾À¸·ÎºÎÅÍ ±«Àú¿Í Ãµ°øÀ» ¼ö¹ÝÇϴ °¨¿°Áõ±îÁö ÀÖ´Ù.
¿µ¹® severe acute respiratory syndrome(SARS) ÇÑ±Û »ç½º
¼³¸í   
  Áß±¹ ±¤µ¿ Áö¿ª¿¡¼­ °¡Àå ¸ÕÀú ¹ß»ýÇÑ Àü¿°¼º È£Èí±â ÁúȯÀ¸·Î ¼¼°èº¸°Ç±â±¸(WHO)¿¡¼­ ¡®ÁßÁõ±Þ¼ºÈ£ÈíÁõÈıº(SARS)'À¸·Î ¸í¸íÇß´Ù. ¼·¾¾ 38µµ ÀÌ»óÀÇ °í¿­°ú ±âħ, È£Èí°ï¶õ, Àú»ê¼ÒÁõ, X¼±»óÀÇ Æó·ÅÁõ»ó Áß Çϳª ÀÌ»óÀÇ Áõ»óÀÌ ³ªÅ¸³ª¸ç, µÎÅë, ±ÙÀ°Åë, ½Ä¿åºÎÁø, ÇǷΰ¨, ¹ßÁø, ¼³»ç¸¦ µ¿¹ÝÇÒ ¼ö ÀÖ´Ù. Ãʱâ Áõ»óÀº °¨±â¿Í ºñ½ÁÇÏÁö¸¸ Æó·ÅÀ¸·Î ¹ßÀüÇϸé Ä¡¸íÀûÀÏ ¼ö ÀÖ´Ù. ÇöÀç ¹àÇôÁø °¨¿°°æ·Î´Â È¯ÀÚ°¡ Àçä±â³ª ±âħÇÒ ¶§ ³»»Õ´Â Ä§¹æ¿ïÀ̰í, À̰ÍÀÌ ´Ù¸¥ »ç¶÷ÀǠȣÈí±â·Î µé¾î°¥ ¶§ Àü¿°µÈ´Ù. Ä§¹æ¿ïÀÌ Àü´ÞµÇ´Â °Å¸®´Â º¸Åë 1m·Î º¸°í ÀÖ´Ù. °ø±â¸¦ ÅëÇØ Àü¿°ÀÌ °¡´ÉÇϴٴ ÁÖÀåÀÌ Á¦±âµÆÁö¸¸ ¾ÆÁ÷ È®ÀεÇÁö ¾Ê¾Ò´Ù. ¿øÀαÕÀº º¯Á¾ Äڷγª¹ÙÀÌ·¯½º·Î ¹àÇôÁ³´Ù. 
  
  
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • half-normal saline
    1/2»ý¸®½Ä¿°¼ö
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • normal
    1. Á¤»ó- 2. ³ë¸£¸»
  • normal antibody
    Á¤»óÇ×ü
  • normal curve
    Á¤±Ô°î¼±
  • normal diet
    º¸ÅëÀ½½Ä
  • normal distribution
    Á¤±ÔºÐÆ÷
  • normal dwarf
    ±ÕÇü³­ÀïÀÌ, Á¤»ó³­ÀïÀÌ
  • normal endometrium
    Á¤»óÀڱ󻸷, Á¤»óÀڱüӸ·
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • normal flora
    Á¤»ó±Õ¹«¸®
  • normal full term delivery
    Á¤»ó¸¸±âºÐ¸¸
  • normal human plasma
    Á¤»ó»ç¶÷Ç÷Àå
  • normal intestinal flora
    âÀÚÁ¤»ó±Õ¹«¸®, Àå³»Á¤»ó±Õ¹«¸®
  • normal limit
    Á¤»óÇѰè
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • normal distribution
    Á¤±ÔºÐÆ÷
  • normal endometrium
    Á¤»óÀڱ󻸷, Á¤»óÀڱüӸ·
  • normal pressure hydrocephalus
    Á¤»ó¾Ð¼öµÎÁõ
  • normal pressure
    Á¤»ó¾Ð, Ç¥ÁؾÐ
  • normal singleton pregnancy
    Á¤»ó¿Üµ¿ÀÓ½Å
  • normal saline
    »ý¸®½Ä¿°¼ö
  • normal value
    Á¤»óÄ¡
  • effect
    È¿°ú, ÀÛ¿ë
  • adverse effect
    (¢¡ adverse event) À¯ÇذæÇè
  • anticoagulant effect
    Ç×ÀÀ°íÈ¿°ú
  • antioxidant effect
    Ç×»êÈ­È¿°ú
  • inhibitory effect
    ¾ïÁ¦È¿°ú
  • palliative effect
    ¿ÏÈ­È¿°ú, °æ°¨È¿°ú
  • prolonged effect
    Áö¼ÓÈ¿°ú
  • radiation effect
    ¹æ»ç¼±È¿°ú
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute normal tissue effect
    Á¤»óÁ¶Á÷±Þ¼º¿µÇâ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • normal fatty acid
    Ç¥ÁØÁö¹æ»ê
  • normal serum albumin
    Á¤»óÇ÷û¾ËºÎ¹Î
  • normal curve
    Á¤±Ô°î¼±
  • normal retinal correspondence
    Á¤»ó¸Á¸·´ëÀÀ
  • full term normal delivery
    ¸¸±âÁ¤»óºÐ¸¸
  • normal diet
    º¸ÅëÀ½½Ä
  • normal distribution
    Á¤±ÔºÐÆ÷
  • normal dwarf
    Á¤»ó³­ÀåÀÌ
  • normal flora
    Á¤»ó±Õ¹«¸®
  • normal intestinal flora
    âÀÚÁ¤»ó±Õ¹«¸®
  • normal tension glaucoma
    Á¤»ó¾È¾Ð³ì³»Àå
  • half-normal solution
    ¹Ý±ÔÁ¤¾×
  • normal pressure hydrocephalus
    Á¤»ó¾Ð¹°³úÁõ, Á¤»ó¾Ð¼öµÎÁõ
  • normal limit
    Á¤»óÇѰè
  • normal
    Á¤»ó-, ³ë¸£¸»
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • NRC->normal retinal correspondence
    Á¤»ó¸Á¸·´ëÀÀ
  • full term normal delivery =FTND
    ¸¸±âÁ¤»óºÐ¸¸(ػѢïáßÈÝÂØ´).
  • full term normal vaginal delivery
    ¸¸±âÁ¤»ó°æÁú½ÄºÐ¸¸.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • hypothetical normal occlusion
    °¡»óÁ¤»ó±³ÇÕ(Ê£ßÌïáßÈÎáùê).
  • individual normal occlusion
    °³¼ºÁ¤»ó±³ÇÕ (ËÁàõïáßÈÎáùê).
  • Connetive tissue
    °áÇÕÁ¶Á÷(Ì¿ùêðÚòÄ)
  • Macrophages tissue
    ´ë½Ä¼¼Æ÷Á¶Á÷(ÓÞãÝá¬øàðÚòÄ)
  • abnormality of tissue
    Á¶Á÷ÀÌ»ó
  • adipose tissue disease
    Áö¹æÁ¶Á÷Áúȯ.
  • angioblastic tissue
    Ç÷°ü¹ß»ýÁ¶Á÷
  • free water in stationary tissue
    Á¤Àû Á¶Á÷³» ÀÚÀ¯ ¼öºÐ
  • general connective tissue
    ÀϹݰáÇÕÁ¶Á÷.
  • gingival tissue esthetics
    Ä¡ÀºÁ¶Á÷½É¹Ì¼º.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute and late normal tissue effects
    Á¤»óÁ¶Á÷ ±Þ¼º¿µÇâ, Á¤»óÁ¶Á÷ ¸¸¼º ¿µÇâ
  • spongy bone tissue [trabecular bone tissue]
    ÇØ¸é»ÀÁ¶Á÷
  • citrated normal human plasma
    Á¤»óÀα¸¿¬»ê¿°Ã·°¡Ç÷Àå.
  • common opsonin =normal o.
    Á¤»ó(ïáßÈ)¿É¼Ò´Ñ.
  • flora, normal
    Á¤»ó¼¼±ÕÃÑ
  • full term normal delivery =FTND
    ¸¸±âÁ¤»óºÐ¸¸(ػѢïáßÈÝÂØ´).
  • full term normal vaginal delivery
    ¸¸±âÁ¤»ó°æÁú½ÄºÐ¸¸.
  • half normal solution
    0.5 ±ÔÁ¤¾×(¡­Ð®ïÒäû).
  • hypothetical normal occlusion
    °¡»óÁ¤»ó±³ÇÕ(Ê£ßÌïáßÈÎáùê).
  • individual normal occlusion
    °³¼ºÁ¤»ó±³ÇÕ (ËÁàõïáßÈÎáùê).
  • last normal menstrual period (LNMP)
    ÃÖÁ¾ Á¤»ó ¿ù°æÀÏ (õÌðû ïáßÈ êÅÌèìí)
  • last normal menstrual period =LNMP
    ÃÖÁ¾Á¤»ó¿ù°æ±â(õÌðûïáßÈêÅÌèÑ¢).
  • logarithmic normal distribution
    ·Î±×Á¤±ÔºÐÆ÷, ´ë¼öÁ¤±ÔºÐÆ÷(ÊÙËøË»ËÓ̰).
  • neutral occlusion =normal o.
    Á¤»ó±³ÇÕ.
  • normal
    1.Á¤»óÀÇ 2.³óµµÀÇ ´ÜÀ§,1±×·¥´ç·®/1000ml
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Spongy bone tissue [Trabecular bone tissue]
    ÇØ¸é»ÀÁ¶Á÷
    [¿¾ ¿ë¾î] ÇØ¸é°ñÁ¶Á÷
  • Skeletal muscular tissue
    °¡·Î¹«´Ì±ÙÀ°Á¶Á÷ [»À´ë±ÙÀ°Á¶Á÷]
    [¿¾ ¿ë¾î] °ñ°Ý±ÙÁ¶Á÷
  • Brown fat tissue
    °¥»öÁö¹æÁ¶Á÷
    [¿¾ ¿ë¾î] °¥»öÁö¹æÁ¶Á÷
  • Subconjunctival tissue
    °á¸·¹ØÁ¶Á÷
    [¿¾ ¿ë¾î] °á¸·ÇÏÁ¶Á÷
  • Lymphoblastic tissue
    ¸²ÇÁ°ü¹ß»ýÁ¶Á÷
    [¿¾ ¿ë¾î] ÀÓÆÄ¸ð¼¼Æ÷Á¶Á÷
  • Smooth musclular tissue
    ¹Î¹«´Ì±ÙÀ°Á¶Á÷ [³»Àå±ÙÀ°Á¶Á÷]
    [¿¾ ¿ë¾î] ÆòȰ±ÙÁ¶Á÷
  • White fat tissue
    ¹é»öÁö¹æÁ¶Á÷
    [¿¾ ¿ë¾î] ¹é»öÁö¹æÁ¶Á÷
  • Loose collagenous connective tissue
    ¼º±ä¾Æ±³°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼Ò¼º°áÇÕÁ¶Á÷
  • Reticular connective tissue
    ¼¼¸Á°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼¸Á°áÇÕÁ¶Á÷
  • Reticular tissue
    ¼¼¸ÁÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼¸ÁÁ¶Á÷
  • Cellular connective tissue
    ¼¼Æ÷¼º°áÇÕÁ¶Á÷
    [¿¾ ¿ë¾î] ¼¼Æ÷¼º°áÇÕÁ¶Á÷
  • Neural crest tissue
    ½Å°æ´É¼±Á¶Á÷
    [¿¾ ¿ë¾î] ½Å°æ¸ªÁ¶Á÷
  • Tissue of neural crest (Mesectoderm)
    ½Å°æ´É¼±Á¶Á÷ (Áß°£¿Ü¹è¿±)
    [¿¾ ¿ë¾î] ½Å°æ¸ªÁ¶Á÷
  • Nervous tissue (Neuroblastoma)
    ½Å°æÁ¶Á÷ (½Å°æ¸ð¼¼Æ÷Á¾)
    [¿¾ ¿ë¾î] ½Å°æÁ¶Á÷
  • Cardiac muscular tissue
    ½ÉÀå±ÙÀ°Á¶Á÷
    [¿¾ ¿ë¾î] ½É±ÙÁ¶Á÷
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bilharzial granulation tissue
    ¹æ±¤ÁÖÇ÷ÈíÃæÀ°¾ÆÁ¶Á÷
  • tissue parasite
    Á¶Á÷±â»ýÃæ
  • tissue selectivity
    Á¶Á÷¼±Åüº
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • normal-phase chromatgoraphy
    Á¤»ó»ó(ïáßÈßÓ) Å©·Î¸¶Åä±×·¡ÇÇ
  • acute porphyria
    ±Þ¼º(Ðáàõ) Æ÷¸£ÇǸ°Áõ (ñø)
  • acute serum
    ±Þä Ç÷û(Ðáóõúìôè)
  • acute test
    ´Ü·® µ¶¼º½ÃÇè (Ó¤ÕáÔ¸àõãËúÐ)
  • adipose tissue
    Áö¹æÁ¶Á÷(ò·Û¸ðÚòÄ)
  • brown adipose tissue
    °¥»öÁö¹æÁ¶Á÷(Êèßäò·Û¸ðÚòÄ)
  • established tissue chluture
    ¼ö¸³ Á¶Á÷¹è¾ç (â§Ø¡ðÚòÄÛÆå×)
  • lipoprotein tissue factor
    ÁöÁú´Ü¹éÁú(ò·òõÓ±ÛÜòõ) Á¶Á÷ÀÎÀÚ(ðÚòÄì×í­)
  • median tissue culture dose
    Á¤ÁßÁ¶Á÷¹è¾ç·®(ïáñéðÚòÄÛÆå×Õá)
  • primary tissue culture
    ÀÏÂ÷ Á¶Á÷¹è¾ç(ìéó­ðÚòÄÛÆå×)
  • tissue culture
    Á¶Á÷¹è¾ç (ðÚòÄÛÆå×)
  • tissue culture infectious dose
    Á¶Á÷¹è¾ç °¨¿°·® (ðÚòÄÛÆå×ÊïæøÕá)
  • tissue factor
    Á¶Á÷ÀÎÀÚ (ðÚòÄì×í­)
  • tissue hormone
    Á¶Á÷(ðÚòÄ)È£¸£¸ó
  • tissue plasminogen activator
    Á¶Á÷(ðÚòÄ)Çö󽺹̳ëÀü Ȱ¼ºÀÚ (üÀàõí­)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • normal range
    Á¤»ó¹üÀ§
  • normal value
    Á¤»óÄ¡, Ç¥ÁØÄ¡, ±ÔÁ¤Ä¡
  • acute
    ±Þ¼º, ¿¹¸®ÇÑ
  • acute abdomen
    ±Þ¼ºº¹Áõ
  • acute angle
    ¿¹°¢
  • acute stage
    ±Þ¼º±â
  • aberrant breast tissue
    ¹ÌÀÔÀ¯¹æÁ¶Á÷
  • areolar tissue
    À±¹®»óÁ¶Á÷
  • connective tissue
    °áÇÕÁ¶Á÷
  • fibrous tissue
    ¼¶À¯¼ºÁ¶Á÷
  • flowing tissue
    À¯µ¿Á¶Á÷, ±â·ù¼ºÁ¶Á÷
  • free water in stationary tissue
    Á¤ÀûÁ¶Á÷³» ÀÚÀ¯¼öºÐ
  • granulation tissue
    À°¾ÆÁ¶Á÷
  • inflammatory tissue
    ¿°ÁõÁ¶Á÷
  • interstitial tissue
    °£ÁúÁ¶Á÷
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
AML Acute Myelogenous Leukemia
  Morphologic Classification(FABºÐ·ù)
   &n...
AML acute monocytic leukemia; acute mucosal lesion; acute myeloblastic leukemia; acute myelocytic leukem...
DEFNT dose-effect factor for normal tissue
AP accessory pathway; accounts payable; acid phosphatase; acinar parenchyma; action potential; active p...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
NTCP Normal Tissue Complication Probability
NTCP Normal tissue complication probabilities
NTCP's normal tissue complication probabilities
ADE Alcohol deprivation effect
AEF Allogeneic effect factors
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • acute and late normal tissue effects£¨Á¤»ó Á¶Á÷ ±Þ¼º ¿µÇ⣩

    acute angle

    ¿¹°¢
    Á÷°¢º¸´Ù ÀÛÀº °¢.
  • acute appendicitis£¨±Þ¼º Ãæ¼ö¿°£©

    acute arthritis

    ±Þ¼º °üÀý¿°
    ¿°Áõ°ú °¨¿°°ú ¿Ü»ó¿¡ ÀÇÇÏ¿© µ¿Åë, ¹ß¿­, ¹ßÀû, Á¾Ã¢ÀÌ ½ÉÇÑ °üÀý¿°.
  • acute mixed-lineage leukmia£¨±Þ¼º È¥ÇÕ-Á÷°è¼º ¹éÇ÷º´£©

    acute monocytic leukemia

    ±Þ¼º ´Ü±¸ ¹éÇ÷º´, ±Þ¼º ´Ü±¸¼º ¹éÇ÷º´
    ±Þ¼º ¹éÇ÷º´ÀÇ ÀÏÁ¾À̰í À¯¾à´Ü±¸°¡ ¹éÇ÷º´È­ÇÑ °ÍÀÌ´Ù. °ñ¼ö¿¡¼­ °ú¸³±¸°èÀÇ À¯¾à¼¼Æ÷¿Í ´Ü±¸°èÀÇ À¯¾à¼¼Æ÷°¡ È¥ÀçÇÏ´Â ¼ö°¡ ÀÖ°í ÀÌ °æ¿ì¿¡´Â ±Þ¼º °ñ¼ö´Ü±¸¼º ¹éÇ÷º´À̶ó°í ÇÑ´Ù.
  • citrated normal human plasma
    Á¤»óÀÎ ±¸¿¬»ê¿° ÷°¡ Ç÷Àå
  • individual normal occlusion
    °³¼º Á¤»ó ±³ÇÕ
    Á¤»ó º¯À̳»¿¡ ÀÖ´Â °³ÀÎÂ÷¸¦ ÀÎÁ¤ÇÏ´Â Á¤»ó±³ÇÕ
  • normal adrenal function
    Á¤»óÀûÀÎ ºÎ½Å ±â´É
  • normal bacteriolysin
    Á¤»ó ¿ë±Õ¼Ò
  • normal curve
    Á¤»ó °î¼±, Á¤±Ô °î¼±
  • normal distribution
    Á¤±Ô ºÐÆ÷
  • normal eruption process
    Á¤»ó ¸ÍÃâ °úÁ¤
  • normal flora
    Á¤»ó ±ÕÃÑ, Á¤»ó ±ÕÃѱº
  • normal immunoglobulin
    Á¤»ó ¸é¿ª
  • normal occlusion
    Á¤»ó ±³ÇÕ
  • normal potential
    Á¤»ó ÀüÀ§
  • normal pressure hydrocephalus
    Á¤»ó¾Ð ¼öµÎÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
beta-normal <radiobiology> Beta-N, the normalised beta, is beta relative to the beta limit.
(09 Oct 1997)
big axillary nodes and normal breasts <radiology> Consider: lymphoma, leukaemia, rheumatoid arthritis
(12 Dec 1998)
gallium uptake with normal chest film <radiology> Pulmonary drug toxicity, tumour infiltration, sarcoidosis, pneumocystis carinii see: lung: gallium imaging
(12 Dec 1998)
range, normal Normal results can fall outside the normal range. By convention, the normal range is set to cover ninety-five percent (95%) of values from a normal population. Five percent (5%) of normal results therefore fall outside the normal range.
(12 Dec 1998)
human normal immunoglobulin A preparation of the proteins of liquid human plasma, containing the antibodies of normal adults; it is obtained from pooled liquid human plasma from a number of donors and may be prepared by precipitation with organic solvents under controlled conditions of pH, ionic strength, and temperature.
Synonym: human normal immunoglobulin.
(05 Mar 2000)
normal <microscopy> An imaginary line forming a right angle with the tangent to a curved surface at a particular point. It is used as a basis for determining angles of incidence, reflection, and refraction.
(05 Aug 1998)
normal animal In research, an experimental animal that has neither suffered an attack of a particular disease nor received an injection of a specific microorganism or its toxin.
(05 Mar 2000)
normal antibody Antibody demonstrable in the serum or plasma of various persons or animals not known to have been stimulated by specific antigen, either artificially or as the result of naturally occurring contact.
Synonym: natural antibody.
(05 Mar 2000)
normal antitoxin Serum that is capable of neutralizing an equivalent quantity of a normal toxin solution.
(05 Mar 2000)
normal bite That arrangement of teeth and their supporting structure which is usually found in health and which approaches an ideal or standard arrangement.
Synonym: normal bite.
Synonym: neutral occlusion.
(05 Mar 2000)
normal butyric acid (also written as n-butyric acid), butanoic acid, CH3CH2CH2COOH, which occurs in combination with glycerol in cow's butter; and isobutyric acid, 2-methylpropanoic acid, (CH3)2CHCOOH, one of the intermediates in valine catabolism, found in combination with glycerol in croton oil and elsewhere.
(05 Mar 2000)
normal cholesteraemic xanthomatosis histiocytosis
normal distribution Continuous frequency distribution of infinite range. Its properties are as follows: 1) continuous, symmetrical distribution with both tails extending to infinity; 2) arithmetic mean, mode, and median identical; and 3) shape completely determined by the mean and standard deviation.
(12 Dec 1998)
normal electrical axis A mean electrical axis of the heart situated between -30
normal hearing The ability to perceive sound normally.
Synonym: normal hearing.
Origin: G. Akousis, hearing
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • acute
    ³¯Ä«·Î¿î; °Ý·ÄÇÑ
  • acute
    ³¯Ä«·Î¿î;»ÏÁ·ÇÑ;¿¹¹ÎÇÑ;ºóÆ´¾ø´Â;°Ý·ÄÇÑ;±Þ¼ºÀÇ
  • tissue
    Á¶Á÷
  • cleansing tissue
    È­Àå¿ë ¹Ú¿±Áö(Ƽ½´ ÆäÀÌÆÛ)
  • connective tissue
    °áÇÕ Á¶Á÷
  • facial tissue
    °í±Þ È­ÀåÁö
  • permanent tissue
    ¿µ±¸ Á¶Á÷
  • tissue
    Á¶Á÷;¾ãÀº Á÷¹°;(°ÅÁþ¸» µûÀ§ÀÇ)µÚ¹ü¹÷;¿¬¼Ó;ź¼Ò ÀÎÈ­Áö
  • normal
    º¸ÅëÀÇ,Á¤»óÀûÀÎ,Á¤»ó»óÅÂ,Æò±Õ,(OPP.abnormal)
  • normal hours
    º¸Åë ½Ã°£´ë
  • normal
    Ç¥ÁØÀÇ;±Ô°Ý´ë·ÎÀÇ;Á¤±ÔÀÇ;ÀüÇüÀûÀÎ;Á¤»óÀÇ;»óÅÂÀÇ;º¸ÅëÀÇ;Æò±ÕÀÇ;(»ç¶÷ÀÌ)Á¤»óÀûÀ¸·Î ¹ß´ÞÇϰí ÀÖ´Â;¼öÁ÷ÀÇ;(¿ë¾×ÀÌ)±ÔÁ¤ÀÇ;(½ÇÇ赿¹°ÀÌ)Á¤»óÀÇ;(¸é¿ªµî)ÀÚ¿¬ÀÇ
  • normal
    »óÅÂ;ÀüÇü;Ç¥ÁØ;Æò±Õ;Æò¿Â;¹ý¼±;¼öÁ÷¼±;Æò±Õ·®;normalness()n
  • normal distribution
    Á¤»óºÐÆ÷
  • normal school
    »ç¹üÇб³(ÇöÀç´Â teachers college·Î °³Äª
  • normal solution
    ±ÔÁ¤¾×
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á